Ledger.Open graph →

SEC Form D · Amendment · filed April 19, 2022

Triana Biomedicines, Inc

Offering

$85.1M

Sold

$42.6M

Exemption

Rule 506(b)

Industry

Pharmaceuticals

Location

WALTHAM, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (22)

Shelley Chu · Waltham, MADirector Simon Read · Waltham, MADirector David Grayzel · Waltham, MADirector Milind Deshpande · Waltham, MADirector Joshua Resnick · Waltham, MADirector Patrick Trojer · Waltham, MAExec · Director Jigar Raythatha · Waltham, MADirector Andrew P. Walrath · Schenectady, NYDirector Richard Y. Bilotti · Piedmont, CADirector Ronald Rosenfarb · CAROLINA, Puerto RicoDirector Michael Esposito · Redondo Beach, CADirector Ethan Y. Huynh · Piedmont, CADirector Nathan Mcgill · Columbus, OHExec · Director Christopher O'Donnel · Waltham, MADirector Tom B. Mccandless · Vancouver, British Columbia, CanadaDirector Jay A. Brammer · Carmel, INDirector Grady J. Gaynor · Carmel, INDirector Oskar Lewnowski · New York, NYExec · Director Jonathan Lamb · New York, NYDirector Peter Rozenauers · New York, NYDirector Jigar Raythatha · Waltham, MADirector Christopher O'Donnel · Waltham, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗